Go to main contentsGo to main menu
Saturday, March 8, 2025 at 8:54 PM
[Voting has ended]

MEDICAID FOR WEIGHTLOSS DRUGS?

GLP-1 drugs like Ozempic and Wegovy, originally developed for diabetes, are increasingly used for weight loss. State Medicaid programs are debating whether to cover these drugs, citing potential health benefits and long-term cost savings. However, some researchers question whether they truly reduce healthcare costs over time. Do you think Medicaid should cover these drugs for weight loss?

Yes, they can improve health outcomes and may save money in the long run.
26%   (6 votes)
No, the cost-effectiveness and long-term benefits are uncertain.
52%   (12 votes)
Unsure, more evidence is needed before I'd make a decision
22%   (5 votes)